514 related articles for article (PubMed ID: 10094567)
1. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism.
Oetting WS; King RA
Hum Mutat; 1999; 13(2):99-115. PubMed ID: 10094567
[TBL] [Abstract][Full Text] [Related]
2. New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene.
Oetting WS
Hum Mutat; 2002 Feb; 19(2):85-92. PubMed ID: 11793467
[TBL] [Abstract][Full Text] [Related]
3. Albinism in Europe.
Mártinez-García M; Montoliu L
J Dermatol; 2013 May; 40(5):319-24. PubMed ID: 23668539
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
[TBL] [Abstract][Full Text] [Related]
5. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
Oetting WS; King RA
Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
Ullah MI
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
Oetting WS; Fryer JP; King RA
Hum Mutat; 1998; 12(6):433-4. PubMed ID: 10671066
[TBL] [Abstract][Full Text] [Related]
10. Oculocutaneous albinism type 1A: a case report.
Karaman A
Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
[TBL] [Abstract][Full Text] [Related]
11. Oculocutaneous albinism.
Grønskov K; Ek J; Brondum-Nielsen K
Orphanet J Rare Dis; 2007 Nov; 2():43. PubMed ID: 17980020
[TBL] [Abstract][Full Text] [Related]
12. [Oculocutaneous albinism].
Lacour JP; Ortonne JP
Ann Pediatr (Paris); 1992 Sep; 39(7):409-18. PubMed ID: 1416662
[TBL] [Abstract][Full Text] [Related]
13. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
Ray K; Chaki M; Sengupta M
Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
[TBL] [Abstract][Full Text] [Related]
14. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
[TBL] [Abstract][Full Text] [Related]
15. The retinal pigmentation pathway in human albinism: Not so black and white.
Bakker R; Wagstaff EL; Kruijt CC; Emri E; van Karnebeek CDM; Hoffmann MB; Brooks BP; Boon CJF; Montoliu L; van Genderen MM; Bergen AA
Prog Retin Eye Res; 2022 Nov; 91():101091. PubMed ID: 35729001
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the human P gene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online.
Oetting WS; Gardner JM; Fryer JP; Ching A; Durham-Pierre D; King RA; Brilliant MH
Hum Mutat; 1998; 12(6):434. PubMed ID: 10671067
[TBL] [Abstract][Full Text] [Related]
17. Syndromic albinism: a review of genetics and phenotypes.
Scheinfeld NS
Dermatol Online J; 2003 Dec; 9(5):5. PubMed ID: 14996378
[TBL] [Abstract][Full Text] [Related]
18. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
[TBL] [Abstract][Full Text] [Related]
19. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
[TBL] [Abstract][Full Text] [Related]
20. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
Preising MN; Forster H; Gonser M; Lorenz B
Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
